Circulating Tumor Cell News and Research

RSS

Label-free microfluidic chip and AI identify blood-borne tumor cells

Finding a few tumor cells hidden among billions of blood cells is one of the biggest challenges in liquid biopsy.

30 Sep 2026

Dual-positive hybrid cells linked to shorter survival in advanced breast cancer

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

11 Mar 2026

Triple negative breast cancer cells use new strategy to boost metastatic ability

Researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize, or spread to other organs.

6 Feb 2026

Platelets found to mop up DNA fragments and improve early cancer detection

Platelets are probably best known for their role in blood clotting, making scabs and related, if less salubrious, contributions to heart attacks and strokes.

2 Sep 2025

Researchers uncover a novel way platelets can suppress inflammation

Platelets are probably best known for their role in blood clotting, making scabs and related, if less salubrious, contributions to heart attacks and strokes. But these tiny, saucer-shaped blood cells have other physiological duties as well, including surveillance for viral or bacterial infections, the recruitment of immune cells to the site of a suspected incursion, and even the direct destruction of pathogens.

18 Aug 2025

Study sheds light on how tumor clusters enter the bloodstream

Tumors are made up of millions of cells, and removing all of these cells surgically or eliminating them with medication becomes much more difficult after the cancer has spread to other parts of the body.

22 May 2025

Liquid biopsy offers new hope for early cancer detection

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

22 Apr 2025

CityUHK leads groundbreaking project to develop new platform for early cancer detection

Cancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, efficient, and early detection methods.

13 Mar 2025

Breakthrough study targets tumor cell clusters to prevent metastasis

Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases.

24 Jan 2025

Researchers grow tumor organoids from blood to tackle breast cancer metastasis

Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are very rare and could not be propagated in the culture dish until now, which made research into therapy resistance difficult.

3 Jan 2025

Early blood test can predict treatment response and survival prospects in metastatic prostate cancer

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest.

7 Oct 2024

Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration

Antibodies validated for use with Bio-Rad’s Celselect Slides™ enumeration stain kits to enable immunostaining of captured circulating tumor cells in liquid biopsy samples.

From Bio-Rad Laboratories 26 Mar 2024

Researchers develop a deep learning model to classify cancer cells by type

Cancer cells that initiate metastasis, or the spread of the disease from its primary location, are different from cancer cells that stay in the original tumor. Distinguishing metastasis-initiating cell types can determine the severity of cancer and help medical practitioners decide on a course of treatment.

2 May 2023

Trial establishes the clinical utility of circulating tumor cell count as biomarker in breast cancer care

The use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-line therapy for patients with metastatic, estrogen receptor (ER)-positive/HER2-negative breast cancer provided overall survival benefit, compared with physician's choice of treatment, according to data from the STIC CTC trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

8 Dec 2022

Researchers develop Cluster-Wells to facilitate the study of circulating tumor cells

Cancer spreads via circulating tumor cells (CTCs) that travel through the blood to other organs, and they are nearly impossible to track. Now, researchers at the Georgia Institute of Technology have found a detection method that could revolutionize cancer treatment by showing how cancers metastasize and what stage they are. This could lead to earlier and more targeted treatment, beginning with a simple blood test.

16 Aug 2022

Circulating Tumor Cell News and Research

Label-free microfluidic chip and AI identify blood-borne tumor cells

Dual-positive hybrid cells linked to shorter survival in advanced breast cancer

Triple negative breast cancer cells use new strategy to boost metastatic ability

Platelets found to mop up DNA fragments and improve early cancer detection

Researchers uncover a novel way platelets can suppress inflammation

Study sheds light on how tumor clusters enter the bloodstream

Liquid biopsy offers new hope for early cancer detection

CityUHK leads groundbreaking project to develop new platform for early cancer detection

Breakthrough study targets tumor cell clusters to prevent metastasis

Researchers grow tumor organoids from blood to tackle breast cancer metastasis

Early blood test can predict treatment response and survival prospects in metastatic prostate cancer

Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration

Researchers develop a deep learning model to classify cancer cells by type

Trial establishes the clinical utility of circulating tumor cell count as biomarker in breast cancer care

Researchers develop Cluster-Wells to facilitate the study of circulating tumor cells

USA–Japan Workshop participants present cutting-edge research on biomarkers for early detection of cancer

Manipulating a specific gene from yeast could lead a new approach to combatting drug resistance

Patient-derived circulating tumor cells could be used to identify drug targets for leptomeningeal disease

UH researcher receives $2.7 million grant to detect cancer biomarkers in blood by counting exosomes

Novel method can improve the detection of circulating tumor cells

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics